Clovis Oncology Inc reports results for the quarter ended in March - Earnings Summary

Clovis Oncology

05/05/2021 16:12

* Clovis Oncology Inc  CLVS.OQ  reported a quarterly adjusted
loss of 64 cents​​ per share for the quarter ended in March. The
mean expectation of six analysts for the quarter was for a loss
of 72 cents per share.
* Revenue fell 10.6% to $38.05 million from a year ago​; 
analysts expected $44.55 million.
* Clovis Oncology Inc's reported EPS for the quarter was a loss
of 64 cents​.
* The mean earnings estimate of analysts had fallen by
about 2.3% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Clovis Oncology Inc shares had fallen by 21.5% this
quarter and gained 14.8% so far this year.
* The company reported a quarterly loss of $66.28 million.
* Wall Street's median 12-month price target for Clovis Oncology
Inc is $5.88 
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and 3 "sell" or "strong sell." 
This summary was machine generated May 5 at 03:12 p.m. GMT. ​All
figures in US Dollars.​